Published in BMJ on December 17, 1988
Graves' ophthalmopathy. West J Med (1993) 0.91
Management of dysthyroid eye disease. Br J Ophthalmol (1991) 0.78
Graves' ophthalmopathy. BMJ (1990) 0.77
Methylprednisolone and Graves' ophthalmopathy. BMJ (1989) 0.75
Endocrinology. Postgrad Med J (1991) 0.75
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment. Endocr Rev (1984) 1.79
A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity. Br Med J (Clin Res Ed) (1984) 1.72
Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab (1973) 1.66
"Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis. J Pediatr (1976) 1.40
Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab (1983) 1.40
Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy. N Engl J Med (1983) 1.17
Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study. J Clin Endocrinol Metab (1980) 1.16
An evaluation of plasma exchange for Graves' ophthalmopathy. Clin Endocrinol (Oxf) (1983) 1.10
Beneficial effects of intensive plasma exchange followed by immunosuppressive therapy in severe Graves' ophthalmopathy. Acta Endocrinol (Copenh) (1986) 1.04
High-dose corticosteroids: their use in treating idiopathic rapidly progressive glomerulonephritis. Arch Intern Med (1979) 1.02
The pathogenesis of Graves' ophthalmopathy. Clin Endocrinol Metab (1985) 0.91
Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy. J Clin Endocrinol Metab (1986) 0.89
Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study. Clin Endocrinol (Oxf) (1987) 0.88
Methylprednisolone in patients with membranous nephropathy and declining renal function. Q J Med (1987) 0.81
Ocular manifestations of thyroid disease. Current concepts. Arch Ophthalmol (1960) 0.80
Evaluation of TBII activity in untreated Graves' disease using solubilised thyroid membranes. Ann Clin Biochem (1985) 0.79
Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry (2001) 4.04
Effects of castration and of sexual hormones on the adrenals of male rats. J Physiol (1938) 3.95
The effects of testosterone and testosterone propionate on adult male rats (compared with those on female rats). Biochem J (1937) 3.42
Novel heterotrimeric kinesin-related protein purified from sea urchin eggs. Nature (1993) 3.22
A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97
The action of testosterone propionate on normal adult female rats. Biochem J (1937) 2.80
Somatomedin: proposed designation for sulphation factor. Nature (1972) 2.63
Correlation between sex hormones, thyroid hormones and desoxycorticosterone as judged by their effects on the weights of organs of gonadectomized rats. Biochem J (1941) 2.61
"Spontaneous" transfer of stimulus control from tact to mand contingencies. Res Dev Disabil (1990) 2.59
Complete sequence of the Rous sarcoma virus env gene: identification of structural and functional regions of its product. J Virol (1983) 2.53
Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab (1994) 2.21
A human XY female with a frame shift mutation in the candidate testis-determining gene SRY. Nature (1990) 2.20
A major outbreak of foodborne gastroenteritis among Air Force personnel during Operation Desert Storm. Mil Med (1993) 2.10
The manifold effects of prolonged administration of sex hormones to female rats. Biochem J (1939) 1.95
The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J Am Geriatr Soc (2000) 1.87
Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene (1998) 1.81
Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction. Br Med J (1967) 1.80
Insulin-like growth factors and their binding proteins. Physiol Rev (1990) 1.79
Prolonged administration of sex hormones to castrated rats. Biochem J (1939) 1.76
Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med (1987) 1.74
Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids (1997) 1.69
Effects of bromocriptine on pituitary tumour size. Br Med J (1979) 1.64
Dissociative disorders in psychiatric inpatients. Am J Psychiatry (1993) 1.59
Corneal and conjunctival calcification in chronic renal failure. Br J Ophthalmol (1973) 1.55
A single-centre study of 1000 consecutive peribulbar blocks. Eye (Lond) (2001) 1.51
Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab (1995) 1.51
Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) (1991) 1.50
'Z-RNA'--a left-handed RNA double helix. Nature (1984) 1.48
Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology (2010) 1.46
Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology (1996) 1.45
Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab (1994) 1.44
Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins. South Med J (2001) 1.43
Allergy of the nervous system: a review. Ann Allergy (1976) 1.41
Critical care research ethics: making the case for non-consensual research in ICU. Crit Care Resusc (2004) 1.39
Anatomical and Histological Studies of an Intersexual Lesser Shrew (Sorex minutus L.), with Special Reference to the Effects of the Male Hormones on the Uterus and Vagina. J Anat (1936) 1.38
Search for neutrinoless double-beta decay in 136Xe with EXO-200. Phys Rev Lett (2012) 1.33
Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7. J Clin Pathol (2009) 1.31
Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf) (1993) 1.30
Glasgow Outcome Scale and Disability Rating Scale: comparative usefulness in following recovery in traumatic head injury. Arch Phys Med Rehabil (1985) 1.29
Lipids in the mouse uterus during early pregnancy. J Endocrinol (1975) 1.29
Possible medication errors in home healthcare patients. J Am Geriatr Soc (2001) 1.27
Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) (1984) 1.25
Plasma pattern of immunoreactive ACTH in normal man and in patients with Nelson's syndrome. Acta Endocrinol (Copenh) (1981) 1.25
Azathioprine in the treatment of thyroid-associated ophthalmopathy. Acta Endocrinol (Copenh) (1990) 1.25
Head injury rehabilitation: benefit of early intervention. Arch Phys Med Rehabil (1982) 1.23
The normal course of separation of the pubes in pregnant mice. J Physiol (1946) 1.22
Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid. Eur J Biochem (1984) 1.20
Further purification and characterization of sulfation factor and thymidine factor from acromegalic plasma. J Clin Endocrinol Metab (1971) 1.18
Evidence for Z-form RNA by vacuum UV circular dichroism. Nucleic Acids Res (1985) 1.18
The action of the dipropionate and benzoate-butyrate of oestradiol on ovariectomized rats. Biochem J (1939) 1.18
Incidence of ocular complications in patients undergoing renal transplantation. Br Med J (1972) 1.17
Early stroke recognition: developing an out-of-hospital NIH Stroke Scale. Acad Emerg Med (1997) 1.17
Ontogenesis of somatomedin and insulin receptors in the human fetus. J Clin Invest (1983) 1.17
Primary hyperparathyroidism in children. Brief review of the literature and a case report. Acta Paediatr Scand (1970) 1.15
Titration of HPV-11 infectivity and antibody neutralization can be measured in vitro. J Invest Dermatol (1995) 1.14
Far upstream regulatory elements enhance position-independent and uterus-specific expression of the murine alpha1(I) collagen promoter in transgenic mice. Gene Expr (1999) 1.14
Immunoreactive somatomedin A in human serum. J Clin Endocrinol Metab (1979) 1.13
Radioreceptor assay for somatomedin A. J Clin Endocrinol Metab (1974) 1.12
Linkage studies of HLA and rheumatoid arthritis in multicase families. Arthritis Rheum (1987) 1.11
Purified human somatomedin A and rat multiplication stimulating activity. Mitogens for cultured fibroblasts that cross-react with the same growth peptide receptors. Eur J Biochem (1978) 1.10
Isolation and characterization of polycyclic aromatic hydrocarbon-degrading Mycobacterium isolates from soil. Microb Ecol (2004) 1.09
Extensive synthesis of poly[r(G-C)] using Escherichia coli RNA polymerase. Arch Biochem Biophys (1985) 1.08
Reduction in size of a pituitary tumor by bromocriptine therapy. N Engl J Med (1979) 1.08
Erythromycin-related dystonic reaction. Am J Emerg Med (1992) 1.08
A theory for the membrane potential of living cells. Eur Biophys J (2000) 1.07
Liver Changes in Male Rats after Castration and Injection of Sex Hormones. Br Med J (1938) 1.06
Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients. Cancer Res (1992) 1.05
What inner ear diseases cause benign paroxysmal positional vertigo? Acta Otolaryngol (2000) 1.04
Evoked brain potentials and disability in brain-damaged patients. Arch Phys Med Rehabil (1977) 1.04
Growth and somatomedins. Vitam Horm (1983) 1.04
Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts. J Infect Dis (1991) 1.04
A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann N Y Acad Sci (1993) 1.03
Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab (1995) 1.03
Quantative determination of the sulphation factor activity in human serum. Acta Endocrinol (Copenh) (1970) 1.03
IGF-II binding on human lymphoid cells: demonstration of a common high affinity receptor for insulin like peptides. Biochem Biophys Res Commun (1984) 1.02
Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia (2008) 1.02
Analysis of the tricho-dento-osseous syndrome genotype and phenotype. Am J Med Genet (1997) 1.02
Somatomedin A levels in serum from healthy children and from children with growth hormone deficiency or delayed puberty. Acta Endocrinol (Copenh) (1980) 1.00
Positive rubella titers in pregnancy: a question of validity. Obstet Gynecol (1979) 1.00
Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab (1996) 1.00
Internet use amongst New Zealand general practitioners. N Z Med J (2000) 0.99
Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) (1995) 0.98
Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab (1999) 0.98
Diffuse pneumocephalus due to Clostridium septicum cerebritis in haemolytic uraemic syndrome: CT demonstration. Neuroradiology (1993) 0.97
The characterization of somatomedin A, isolated by microcomputer-controlled chromatography, reveals an apparent identity to insulin-like growth factor 1. Eur J Biochem (1984) 0.97
Observation of two-neutrino double-beta decay in 136Xe with the EXO-200 detector. Phys Rev Lett (2011) 0.97
Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). J Clin Endocrinol Metab (1993) 0.96
G6PD Viangchan: a new glucose 6-phosphate dehydrogenase variant from Laos. Hum Genet (1988) 0.96
Effect of prospectively measured pregnancy intentions on the consistency of contraceptive use among young women in Michigan. Hum Reprod (2012) 0.96
Hyperprolactinaemia in men-response to bromocriptine therapy. Lancet (1982) 0.96
Evaluation of magnetic resonance myelography in the investigation of cervical spondylotic radiculopathy. Br J Radiol (2003) 0.95
A gas chromatographic mass spectrometric assay for plasma trifluoperazine concentrations following single doses. Biomed Mass Spectrom (1982) 0.95
Estrogen treatment of tall girls: dose dependency of effects on subsequent growth and IGF-I levels in blood. Acta Paediatr Scand (1991) 0.95
Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. Eur J Clin Invest (1990) 0.95
Mild traumatic brain injury in an insured population: subjective complaints and return to employment. Brain Inj (1992) 0.95
Health policies in British medical schools. BMJ (1994) 0.94
Somatization in patients with dissociative disorders. Am J Psychiatry (1994) 0.94
Sulphation factor activity and growth rate during long-term treatment of patients with pituitary dwarfism with human growth hormone. Acta Endocrinol (Copenh) (1972) 0.93
Dependence of 4'-(hydroxymethyl)-4,5',8-trimethylpsoralen photoaddition on the conformation of ribonucleic acid. Biochemistry (1982) 0.93
Adrenergic supersensitization as a therapeutic tool in glaucoma. Trans Ophthalmol Soc U K (1974) 0.93